drugset / Trial / NCT03365999

Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement.

NCT03365999

Phase 2 Completed 92 enrolled Autonomous University of Nuevo León
RandomizedParallel-groupSingle-blindPrevention

Summary

This study compares two oral medications (tranexamic acid and aminocaproic acid) as hemostatic agent administered in patients undergoing total knee replacement.

Timeline

Start
2017-10-15
Primary completion
2019-07-01
Completion
2019-07-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminocaproic Acid Small molecule 1 g Oral
Comparator Tranexamic Acid Small molecule 1.3 g Oral